BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32362932)

  • 21. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
    Patel VB; Lezutekong JN; Chen X; Oudit GY
    Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
    Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
    Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE2-Ang (1-7) axis is induced in pressure overloaded rat model.
    Liang B; Li Y; Han Z; Xue J; Zhang Y; Jia S; Wang C
    Int J Clin Exp Pathol; 2015; 8(2):1443-50. PubMed ID: 25973029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
    Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
    J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE and ACE2 in kidney disease.
    Mizuiri S; Ohashi Y
    World J Nephrol; 2015 Feb; 4(1):74-82. PubMed ID: 25664248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
    Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.
    Ferreira AJ; Murça TM; Fraga-Silva RA; Castro CH; Raizada MK; Santos RA
    Int J Hypertens; 2012; 2012():147825. PubMed ID: 22319643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
    Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
    Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.
    Gowrisankar YV; Clark MA
    J Neurochem; 2016 Jul; 138(1):74-85. PubMed ID: 27085714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.
    Wang W; Patel VB; Parajuli N; Fan D; Basu R; Wang Z; Ramprasath T; Kassiri Z; Penninger JM; Oudit GY
    J Mol Med (Berl); 2014 Aug; 92(8):847-58. PubMed ID: 24728465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    Basu R; Poglitsch M; Yogasundaram H; Thomas J; Rowe BH; Oudit GY
    J Am Coll Cardiol; 2017 Feb; 69(7):805-819. PubMed ID: 28209222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session.
    Yang CW; Lu LC; Chang CC; Cho CC; Hsieh WY; Tsai CH; Lin YC; Lin CS
    Ren Fail; 2017 Nov; 39(1):719-728. PubMed ID: 29157100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
    Kanda T; Itoh H
    Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
    Santos RA; Ferreira AJ; Verano-Braga T; Bader M
    J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
    Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
    Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
    Yu C; Tang W; Wang Y; Shen Q; Wang B; Cai C; Meng X; Zou F
    Cancer Lett; 2016 Jul; 376(2):268-77. PubMed ID: 27063099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
    Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
    J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.